Used as a key chiral intermediate in the synthesis of anticoagulant pharmaceuticals, particularly in the production of novel factor Xa inhibitors. Its stereochemistry enables selective binding to target enzymes, enhancing drug efficacy and reducing off-target effects. Commonly employed in research settings for developing new cardiovascular therapies. Also utilized in asymmetric synthesis routes due to its stable chiral center and functional group compatibility.